6 citations
,
September 2024 in “Current Oncology” Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.
June 2024 in “JEADV Clinical Practice” Severe alopecia areata patients have a low chance of spontaneous hair regrowth.
August 2023 in “Clinical and Experimental Dermatology” The document discusses a special exam case for formulating and using systemic therapy named Athena.
November 2022 in “Piretc” The document provides a way to measure how new ideas affect the making of goods in a region.
November 2013 in “Hair transplant forum international” Hair transplant surgeons in the British Association of Hair Restoration Surgery must follow specific behavior and performance rules.
7 citations
,
June 2021 in “Journal of Cosmetic Dermatology” Formulation H2 was the best natural herbal shampoo with good smell and hair benefits.
Henna extracts effectively fight fungi.
November 2022 in “Zenodo (CERN European Organization for Nuclear Research)”
January 2024 in “International Journal of Dermatology Venereology and Leprosy Sciences” Tofacitinib may be safe and effective for treating certain skin conditions in children.
November 2025 in “Clinical Cosmetic and Investigational Dermatology” Tofacitinib is effective and safe for treating severe alopecia areata.
1 citations
,
May 2018 in “Research & Reviews: Journal of Herbal Science” The research helps standardize Henna leaf for safe use in traditional medicine and hair care.
21 citations
,
April 2018 in “The Journal of urology/The journal of urology” SER120 nasal spray effectively reduces nighttime urination and is safe for patients.
August 2021 in “Pharmacy Today” The document's conclusion about hair loss cannot be determined.
3 citations
,
July 2025 in “Clinical and Experimental Dermatology” Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.
Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.
November 1996 in “Hair transplant forum international” The document's conclusion cannot be provided because the document is not accessible.
2 citations
,
September 2025 in “Journal of Dermatological Treatment” Shorter alopecia areata episodes lead to better baricitinib treatment outcomes.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” The herbal shampoo effectively cleanses, nourishes, and promotes hair growth without causing skin irritation.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” The herbal shampoo effectively cleanses, nourishes, and promotes hair growth without causing skin irritation.
MTX and GC combinations are the most effective for early rheumatoid arthritis.
39 citations
,
January 2019 in “Journal of the American Academy of Dermatology” Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.
2 citations
,
March 2022 in “Dermatologic Therapy” Latanoprost 0.005% solution safely increases hair density and regrowth in scalp alopecia areata.
1 citations
,
June 2024 in “European Journal of Dentistry” Human placental extract may be better for tooth repair than current materials.
April 2024 in “JOURNAL OF Mental Health Concerns” Self-affirmation therapy significantly reduces student anxiety before presentations.
33 citations
,
December 2023 in “Cell Death Discovery” Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.
3 citations
,
July 2018 in “DergiPark (Istanbul University)” Medicinal plants in European Turkey are used to treat skin issues like hemorrhoids, hair loss, burns, acne, and injuries.
20 citations
,
June 2003 in “Neurology” Tacrolimus and corticosteroids can improve symptoms of Satoyoshi syndrome.
January 2016 in “Huanjing yu Jiankang Zazhi”
November 2019 in “International journal of research in Ayurveda and pharmacy” A man regrew hair in 15 days using Pracchana and cupping therapy.
December 2025 in “Drug Design Development and Therapy” Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.